This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing the FDA approval of the Revi System, a tibial nerve stimulation system developed by BlueWind Medical for overactive bladder

Ticker(s): BLUEWIND MEDICAL, ALPMY, MDT, PFE

Who's the expert?

Institute: South Texas Womens Institute

  • OBGYN physician at South Texas Womens Institute
  • Manages 50 overactive bladder patients a month

Interview Questions
Q1.

Describe your background and patient setting 

Added By: ben_admin
Q2.

How many patients with overactive bladder do you manage?

Added By: ben_admin
Q3.

What is your opinion of the Revi System?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.